Stay updated with breaking news from Integrative Screening Process. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
16.02.2022 - GOTHENBURG, SWEDEN / ACCESSWIRE / February 16, 2022 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA)IRLAB Therapeutics AB (publ) will publish the year-end report for the period January - December 2021 on Wednesday 23 February 2022 at 07:45 CET. A ...
GOTHENBURG, SE / ACCESSWIRE / December 31, 2021 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA)IRLAB (Nasdaq Stockholm: IRLAB A). Martin Nicklasson has announced his intention to leave the board in January
IRLAB Obtains Regulatory Approval to Conduct Phase IIb Study With Pirepemat – One Step Closer To Improving Balance and Reducing Fall Injuries For People Living With Parkinson’s Disease - read this article along with other careers information, tips and advice on BioSpace
GOTHENBURG, SWEDEN / ACCESSWIRE / December 22, 2021 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA)IRLAB (Nasdaq Stockholm: IRLAB A) IRLAB receives regulatory approval from the Swedish MPA for conducting
GOTHENBURG, SE / ACCESSWIRE / November 5, 2021 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA)IRLAB Therapeutics AB (publ) will publish the interim report for the period January - September 2021 on Wednesday